// App-Quantinova.ai

: "Function First" Screen of Primary AML Cells Identifies Common and Personalised Therapeutic Targets

Researchers

Presenter

  • Jamshid S Khorashad

Principal Investigators

  • Carme Ripoll Fiol

  • Eva Yebra-Fernandez

  • Elisabet Nadal-Melsio

  • Mahroo Karimpoor

  • Simone Claudiani

  • Alistair Reid

  • Steven Knapper

  • Kikkeri Naresh

  • Jane Apperley

  • Clinton C. Mason

Medical Centers

  • Department of Haematology, Imperial College London, Hammersmith Hospital, London, United Kingdom

  • Department of Haematology, Hammersmith Hospital, Imperial Healthcare NHS Trust, London, United Kingdom

  • Centre for Haematology, Department of Medicine, Imperial College London, London, United Kingdom

  • Molecular Pathology Unit, Royal Liverpool University Hospital, Liverpool University, Liverpool, United Kingdom

  • Department of Haematology, Cardiff University, School of Medicine, Cardiff, United Kingdom

  • Department of Surgery & Cancer, Imperial College London, London, United Kingdom

  • Centre for Haematology, Imperial Collegel, London, United Kingdom

  • Department of Medicine, Division of Oncology, University of Utah, Salt Lake City, UT

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved